BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17074068)

  • 1. Biphasic alterations in serotonin-1B (5-HT1B) receptor function during abstinence from extended cocaine self-administration.
    O'Dell LE; Manzardo AM; Polis I; Stouffer DG; Parsons LH
    J Neurochem; 2006 Dec; 99(5):1363-76. PubMed ID: 17074068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.
    Przegaliński E; Gołda A; Frankowska M; Zaniewska M; Filip M
    Eur J Pharmacol; 2007 Mar; 559(2-3):165-72. PubMed ID: 17291490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels.
    O'Dell LE; Parsons LH
    J Pharmacol Exp Ther; 2004 Nov; 311(2):711-9. PubMed ID: 15226384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine.
    Ben-Shahar O; Keeley P; Cook M; Brake W; Joyce M; Nyffeler M; Heston R; Ettenberg A
    Brain Res; 2007 Feb; 1131(1):220-8. PubMed ID: 17161392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT(1B) receptors in nucleus accumbens efferents enhance both rewarding and aversive effects of cocaine.
    Barot SK; Ferguson SM; Neumaier JF
    Eur J Neurosci; 2007 May; 25(10):3125-31. PubMed ID: 17509084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine.
    Parsons LH; Koob GF; Weiss F
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1182-91. PubMed ID: 7562486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupuncture attenuates cocaine-induced expression of behavioral sensitization in rats: possible involvement of the dopaminergic system in the ventral tegmental area.
    Lee B; Han SM; Shim I
    Neurosci Lett; 2009 Jan; 449(2):128-32. PubMed ID: 18992788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
    Yan QS; Zheng SZ; Feng MJ; Yan SE
    Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis.
    Yan QS; Zheng SZ; Yan SE
    Brain Res; 2004 Sep; 1021(1):82-91. PubMed ID: 15328035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine.
    Chefer VI; Morón JA; Hope B; Rea W; Shippenberg TS
    Neuroscience; 2000; 101(3):619-27. PubMed ID: 11113311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Przegaliński E; Vetulani J
    J Neural Transm (Vienna); 2007 Mar; 114(3):307-17. PubMed ID: 16897599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active versus passive cocaine administration: differences in the neuroadaptive changes in the brain dopaminergic system.
    Stefański R; Ziółkowska B; Kuśmider M; Mierzejewski P; Wyszogrodzka E; Kołomańska P; Dziedzicka-Wasylewska M; Przewłocki R; Kostowski W
    Brain Res; 2007 Jul; 1157():1-10. PubMed ID: 17544385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats.
    Berglind WJ; See RE; Fuchs RA; Ghee SM; Whitfield TW; Miller SW; McGinty JF
    Eur J Neurosci; 2007 Aug; 26(3):757-66. PubMed ID: 17651427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence for an abstinence-induced switch in 5-HT1B receptor modulation of cocaine self-administration and cocaine-seeking behavior.
    Pentkowski NS; Harder BG; Brunwasser SJ; Bastle RM; Peartree NA; Yanamandra K; Adams MD; Der-Ghazarian T; Neisewander JL
    ACS Chem Neurosci; 2014 Mar; 5(3):168-76. PubMed ID: 24369697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats.
    Tang W; Wesley M; Freeman WM; Liang B; Hemby SE
    J Neurochem; 2004 May; 89(4):1021-33. PubMed ID: 15140200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal Dopamine Release Kinetics in the Accumbens Core and Shell Are Distinctly Altered after Withdrawal from Cocaine Self-Administration.
    Saddoris MP
    eNeuro; 2016; 3(5):. PubMed ID: 27752541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
    Santucci AC; Madeira E
    Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats.
    Lu L; Grimm JW; Shaham Y; Hope BT
    J Neurochem; 2003 Jun; 85(6):1604-13. PubMed ID: 12787079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats.
    Przegaliński E; Papla I; Siwanowicz J; Filip M
    Eur Neuropsychopharmacol; 2004 May; 14(3):217-25. PubMed ID: 15056481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.